Stocks
Health Care
zntl
Zentalis Pharmaceuticals
NASDAQ: ZNTL
+2.20 (+49.66%)
6.615
USD
At close at Apr 10, 20:43 UTC
Overview
Loading chart...
Key Stats
Market Cap
319.35M
Dividend Yield
0.00%
P/E Ratio
-2.33
EPS
-2.32
Revenue
-
Avg. Volume
3.77M
Recently from Cashu
No Cashu articles
Zentalis Pharmaceuticals currently has no Cashu-related articles
About
What does ZNTL do?
Zentalis Pharmaceuticals, a San Diego-based clinical-stage biopharmaceutical company, develops novel small molecule therapeutics for cancer, including WEE1 inhibitor azenosertib and BCL-2 inhibitor ZN-d5. The company went public on April 3, 2020, and employs 168 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.